Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Time to Sell?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) gapped down prior to trading on Monday . The stock had previously closed at $34.27, but opened at $33.01. Otsuka shares last traded at $34.55, with a volume of 2,499 shares.

Wall Street Analysts Forecast Growth

OTSKY has been the topic of several research analyst reports. Morgan Stanley raised shares of Otsuka to an “overweight” rating in a report on Friday, January 23rd. UBS Group raised Otsuka to a “hold” rating in a research note on Tuesday, January 27th. The Goldman Sachs Group cut Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. Finally, Zacks Research lowered Otsuka from a “hold” rating to a “strong sell” rating in a research note on Monday, March 2nd. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce”.

Otsuka Trading Up 1.1%

The stock’s 50 day simple moving average is $31.22 and its 200 day simple moving average is $29.04. The firm has a market cap of $37.23 billion and a PE ratio of 15.07. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.